Search for: "In Re B & W Management, Inc." Results 201 - 220 of 301
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2013, 7:45 am by Schachtman
  In In re Rigel Pharmaceuticals, Inc. [read post]
25 Aug 2008, 1:11 am
Carl Gaeth was employed as a sales manager at Oracle Corp. from 1986 until 1989. [read post]
18 Jul 2014, 10:40 am by nedaj
The new versions of Form W-8BEN for individuals and entities can be found on the IRS website (see Form W-8BEN and Form W-8BEN-E). [read post]
24 Jun 2010, 3:16 am by Andrew Lavoott Bluestone
  "In 2000 and 2001, defendant Clingman and others formed a company called Marquis Jet Partners, Inc. [read post]
30 Jul 2008, 12:13 am
" Citing In re Silenus Wines, 557 F.2d 806 (CCPA 1977). [read post]
2 Aug 2008, 12:54 am
– Technological Innovation and Intellectual Property), IP and start-ups: (Technological Innovation and Intellectual Property), Innovators: Make sure your company owns the fruits of your open innovation projects: (IP Asset Maximizer Blog), It’s all about the numbers: SuperCrunchers of patent data will gain competitive advantage: (IP Asset Maximizer Blog)   Events 4-9 August: Dept Science & Technology indigenous knowledge systems expo and workshop –… [read post]
3 Sep 2021, 2:05 pm by Bill Marler
§555(b), in particular, requires that “[w]ith due regard for the convenience and necessity of the parties…and within a reasonable time, each agency shall proceed to conclude a matter presented to it. [read post]
22 Dec 2020, 9:43 am by CFM Admin
Managers who no longer qualify for SEC registration as of the time of filing the annual Form ADV amendment must withdraw from SEC registration within 180 days after the end of their fiscal year (June 30, 2021, for most managers), by filing a Form ADV-W. [read post]
6 Jul 2021, 4:23 am by Franklin C. McRoberts
In this week’s New York Business Divorce, we’re excited to write about what seems to be the very first New York appellate court decision in a marijuana industry business divorce dispute. [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]
23 Oct 2017, 4:22 pm by Kevin LaCroix
  Armed with an ever-evolving standard of care, corporate shareholders may be able to hold corporations and their management responsible for flawed or inadequate cybersecurity decision-making, which would inevitably lead to heightened exposure risks for D&O insurers in this volatile area. [read post]
23 Oct 2017, 4:22 pm by Kevin LaCroix
  Armed with an ever-evolving standard of care, corporate shareholders may be able to hold corporations and their management responsible for flawed or inadequate cybersecurity decision-making, which would inevitably lead to heightened exposure risks for D&O insurers in this volatile area. [read post]